Description: Roquefort Investments plc, an investment company, intends to acquire businesses focused on early-stage opportunities in the medical biotechnology sector. It focuses on drug and vaccine development, diagnostics, immuno-therapy, and cell and gene therapy areas. The company was incorporated in 2020 and is based in London, the United Kingdom.
Home Page: www.roquefortinvest.com
ROQ Technical Analysis
Eccleston Yards
London,
SW1W 9NF
United Kingdom
Phone:
44 20 3290 9339
Officers
| Name | Title |
|---|---|
| Mr. Stephen Paul West B.Com, CA | Exec. Chairman |
| Mr. Trevor Ajanthan Reginald | CEO & Exec. Director |
| Prof. Martin J. Evans FRS | Group Chief Scientific Officer & Exec. Director |
| Dr. Armand Keating M.D. | Independent Chief Medical Officer |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.6251 |
| Price-to-Sales TTM: | 13938.873 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1 |